Bowen, Joanne M. http://orcid.org/0000-0003-0876-0031
,
Gibson, Rachel J.
Coller, Janet K.
Blijlevens, Nicole
Bossi, Paolo
Al-Dasooqi, Noor
Bateman, Emma H.
Chiang, Karen
de Mooij, Charlotte
Mayo, Bronwen
Stringer, Andrea M.
Tissing, Wim
Wardill, Hannah R.
van Sebille, Ysabella Z. A.
Ranna, Vinisha
Vaddi, Anusha
Keefe, Dorothy MK.
Lalla, Rajesh V.
Cheng, Karis Kin Fong
Elad, Sharon
Article History
Received: 31 January 2019
Accepted: 22 May 2019
First Online: 8 July 2019
Compliance with ethical standards
:
: These authors disclose no relevant conflict of interest: JC, NB, NA, EB, KC, CDM, BM, AS, WT, HW, YVS, VR, AV, KKFC, SE. JB and RG are MASCC board members.PB has served an advisory role for AstraZeneca, Helsinn, and Kyowa Kyrin and received grants from Merck, Kyowa Kyrin, and Roche. DK is on the advisor board for Zealand Pharma and Helsinn, the speakers bureau for Merck and Mundipharma, and a consultant for Entrinsic Health Solutions. RVL has served as a consultant for Colgate Oral Pharmaceuticals, Galera Therapeutics, Ingalfarma SA, Monopar Therapeutics, Mundipharma, and Sucampo Pharma; has received research support to his institution from Galera Therapeutics, Novartis, Oragenics, and Sucampo Pharma, and has received stock in Logic Biosciences.